Clinical Trials Service Unit, Richard Doll Building, Old Road Campus, Roosevelt Drive, Oxford OX3 7LF, UK. derrick.bennett @ ctsu.ox.ac.uk
Neuroepidemiology. 2012;38(1):30-40. doi: 10.1159/000334744.
Setting priorities for the prevention of stroke requires an empirical understanding of the pattern of disease burden and exposure to major risk factors. In this manuscript we aim to report the methodology of a systematic review of the epidemiological literature on stroke and how this information will be synthesized to produce updated estimates of the global burden of stroke.
We will use multi-state models implemented in the software program DisMod III to estimate age-specific prevalence, incidence, and early case-fatality (defined as either 28-day, 30-day or 1-month case fatality) for stroke by the 21 global burden of disease (GBD) regions as well as by gender and pathological stroke type based on information obtained from a systematic review. We conducted a two-stage search strategy in order to identify studies published between 1980 and 2011 for the GBD stroke review. Eligible studies: (a) distinguished between stroke and transient ischaemic attack (TIA); (b) distinguished between 1st ever and recurrent stroke; (c) reported on age-specific rates; (d) if reported, provided survival status within 28 days, 30 days or 1 month of onset for fatal and nonfatal events; (e) specified methods for ascertaining stroke cases, and (f) described imaging modalities to determine stroke subtypes. Details of included studies were recorded on a detailed data extraction form by trained reviewers. We will gather information on demographics, natural history and clinical outcomes (e.g. Rankin scale, Glasgow Coma Scale), after stroke which will be used to facilitate the estimation of epidemiological parameters. Reporting and methodological quality was rated. Populations were coded as urban, rural, or combined and studies classified as national, subnational, healthcare system-based, or community level. Studies published in non-English languages were translated and coded centrally.
In international health research, there is a crucial need for accurate assessment of global health patterns. A thorough GBD reassessment of stroke will ensure that global health policy decisions are based on the most up-to-date, valid and reliable epidemiological information available.
为预防中风确定优先事项需要对疾病负担模式和主要危险因素暴露情况有一个经验性的了解。在本研究中,我们旨在报告一项关于中风的流行病学文献系统评价的方法学,并说明如何综合这些信息以产生中风全球负担的最新估计。
我们将使用多状态模型,并在软件程序 DisMod III 中实施,根据系统评价中获得的信息,按 21 个全球疾病负担(GBD)区域以及性别和病理类型,估计全球中风负担的年龄特异性患病率、发病率和早期病死率(定义为 28 天、30 天或 1 个月病死率)。我们开展了一项两阶段的检索策略,以确定 1980 年至 2011 年期间发表的 GBD 中风研究。合格的研究需满足以下标准:(a)区分中风和短暂性脑缺血发作(TIA);(b)区分首发和复发中风;(c)报告年龄特异性率;(d)如果报告,提供发病后 28 天、30 天或 1 个月内致命和非致命事件的生存状态;(e)指定确定中风病例的方法;(f)描述确定中风类型的影像学模式。经过培训的审查员将在详细的数据提取表上记录纳入研究的详细信息。我们将收集中风后人口统计学、自然病史和临床结果(如 Rankin 量表、格拉斯哥昏迷量表)信息,这些信息将用于促进流行病学参数的估计。我们将对报告和方法学质量进行评分。人群编码为城市、农村或两者兼有,研究分类为国家、次国家、基于医疗保健系统或社区水平。非英文发表的研究将进行翻译和集中编码。
在国际卫生研究中,准确评估全球卫生模式至关重要。对中风的全面 GBD 再评估将确保全球卫生决策基于现有最新、最有效和最可靠的流行病学信息。